Topics:

Multiple sclerosis

Multiple sclerosis

A switch to a second-line drug in a patient receiving first-line therapies likely will be effective at decreasing disease activity.

Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.

Do you have a patient with "radiologically isolated syndrome" -- and, if so, what do you tell your patient?

Highlights of recent findings about multiple sclerosis are summarized in this slide show.

An FDA-approved drug for high blood pressure alleviates clinical symptoms of MS in mice, showing great promise for humans.

This treatment may be superior to current treatment for patients with severe multiple sclerosis that is not responding well to standard treatments.

A new study indicates that infection with Helicobacter pylori might lower the risk of multiple sclerosis, at least in women. Pharmaceutical products could provide a novel means of treatment.

Pages

Subscribe to Multiple sclerosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.